Literature DB >> 6342710

Immunohistochemical localization of creatine kinase BB-isoenzyme in human brain: comparison with tubulin and astroprotein.

T Yoshimine, K Morimoto, H A Homburger, T Yanagihara.   

Abstract

The distribution of creatine kinase BB-isoenzyme in the human central nervous system (CNS) was investigated immunohistochemically and the findings were compared with the distributions of tubulin and astroprotein. Creatine kinase BB-isoenzyme existed both in neurons and astrocytes, and was universally distributed within the CNS. Tubulin was visualized only in the neuronal elements, namely perikarya, dendrites and axons, while astroprotein was exclusively visualized in astrocytes. A combination of immunohistochemistry for structural and soluble proteins may be a useful tool for the investigation of pathophysiological conditions within the CNS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342710     DOI: 10.1016/0006-8993(83)91338-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis.

Authors:  T Wallimann; M Wyss; D Brdiczka; K Nicolay; H M Eppenberger
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

2.  Diagnostic value of creatine kinase activity in canine cerebrospinal fluid.

Authors:  Alexandra Ferreira
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

3.  Enzymatic changes in the cerebrospinal fluid as indices of pathological change.

Authors:  A Paşaoğlu; H Paşaoğlu
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Pathology of brain parenchyma in meningeal carcinomatosis; immunohistochemical study with astroprotein (GFAP) and tubulin.

Authors:  J Jamshidi; T Yoshimine; Y Ushio; T Hayakawa; K Morimoto; H Mogami
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry.

Authors:  E A Sistermans; Y J de Kok; W Peters; L A Ginsel; P H Jap; B Wieringa
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

6.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

7.  Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.

Authors:  Dae Won Kim; Seong-Il Yeo; Hea Jin Ryu; Ji-Eun Kim; Hong-Ki Song; Oh-Shin Kwon; Soo Young Choi; Tae-Cheon Kang
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

8.  Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.

Authors:  A Kruse; K G Cesarini; F W Bach; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Effects of acrylamide and acrylic acid on creatine kinase activity in the rat brain.

Authors:  K Kohriyama; M Matsuoka; H Igisu
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.

Authors:  H Tomimoto; J M Brengman; T Yanagihara
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.